Logos Global Management LP's Net Worth

-$4.96 Million

Estimate Recalculated Nov 1, 2024 06:37AM EST

Who is Logos Global Management LP?

Logos Global Management LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Dyne Therapeutics, Inc., Verve Therapeutics, Inc., and Novus Therapeutics, Inc..

SEC CIK

Logos Global Management LP's CIK is 0001792126

Past Insider Trading and Trends

2021 was Logos Global Management LP's most active year for acquiring shares with 1 total transactions. Logos Global Management LP's most active month to acquire stocks was the month of May. 2021 saw Logos Global Management LP paying a total of $7,030,000.00 for 370,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dyne Therapeutics, Inc. (DYN) Snapshot price: $33.03

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.5M
$19.00
—
1.5M
Sep 21
Form 3
—
0
—
—
0
No matching records found

Verve Therapeutics, Inc. (VERV) Snapshot price: $5.595

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
813.26K
$19.00
$7,030,000.00
813.26K
Jun 21
Form 3
—
0
—
—
0
No matching records found

Novus Therapeutics, Inc. (ELDN) Snapshot price: $2.664

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+54.53%
79.07K
$26.04
$1,996,154.91
224.07K
Oct 30
Form 3
—
0
—
—
0
No matching records found